Products

Vivio® LVEDP System
Ventric Health
Cardiology AI
Vivio® is the first and only medical device to enable non-invasive diagnosis of heart failure within clinical or home health care environments, leveraging advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP).

See all 1 product →

About Ventric Health

Ventric Health is a Pasadena-based medical technology company dedicated to advancing cardiovascular health through innovative, non-invasive diagnostic solutions. The company’s flagship product, the Vivio® System, is an FDA-cleared medical device designed to easily and non-invasively assess cardiovascular health, specifically by measuring elevated left ventricular end diastolic pressure (LVEDP), a key indicator of heart failure. This technology aims to address the significant challenge of delayed heart failure diagnosis, which often leads to reduced quality of life and increased healthcare costs.

For physicians, the Vivio System offers a pragmatic and accessible approach to heart failure screening in primary care settings. It utilizes a modified blood pressure cuff, a single-lead Bluetooth-enabled ECG, and a proprietary, physics-based algorithm to quickly and accurately compute LVEDP in a five-minute test. This enables earlier identification of patients with heart failure, including those with subclinical cardiac changes, allowing for timely initiation of guideline-directed medical therapy (GDMT) and potentially reducing emergency room visits and hospitalizations. By providing objective, real-time cardiovascular data at the point of care, Ventric Health empowers clinicians to make more confident diagnoses and improve patient outcomes.

Focus Areas

Cardiovascular health early heart failure detection non-invasive diagnostics left ventricular end-diastolic pressure (LVEDP) measurement primary care home health care

Business Intelligence

Key InvestorsPing An Insurance (Group) Company of China, Shanda (Private Equity)
PartnershipsMedical groups, medical centers, home health care organizations, advisory board of experts in cardiology, outcomes research, market access and health technology
TechnologyMobile, tech-enabled device (Vivio System) using advanced algorithms and AI/machine learning for non-invasive measurement of LVEDP via blood pressure cuff and ECG.
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Specialization: Early Heart Failure Detection
Ventric Health specializes in the early and accurate detection of heart failure (HF) using its Vivio System. This system is designed to identify HF before symptoms significantly worsen, enabling proactive management.
Core Diagnostic: Non-invasive LVEDP Measurement
The company's flagship product, the Vivio System, is the first and only FDA-cleared Class II medical device that non-invasively measures Left Ventricular End-Diastolic Pressure (LVEDP), which is considered the gold standard for heart failure diagnosis.
Care Settings: Primary Care & Home Health
Ventric Health's technology is specifically designed for use in primary care settings and home health care environments, making advanced cardiovascular diagnostics more accessible.
Key Differentiator: Superior Accuracy & Sensitivity
The Vivio System has demonstrated 80% sensitivity and 83% specificity in detecting heart failure using LVEDP. It shows six times greater sensitivity than echocardiography and twice the sensitivity of B-type natriuretic peptide (BNP) blood tests for HF detection.
Technology: Rapid, Portable & AI-Powered
The Vivio System is a mobile, tech-enabled device that provides real-time results in under five minutes. It utilizes a modified blood pressure cuff, a single-lead Bluetooth-enabled ECG, and advanced, physics-based algorithms to compute LVEDP.
Physician Tip

For physicians, Ventric Health's Vivio System offers a unique opportunity to significantly improve early heart failure diagnosis and management. Its non-invasive nature eliminates the risks and costs associated with invasive LVEDP measurements, making it a practical tool for routine primary care visits. The rapid, objective results enable earlier initiation of guideline-directed medical therapy (GDMT), potentially reducing hospitalizations, ER visits, and improving patient quality of life. The system's ability to identify elevated LVEDP, even in asymptomatic or early-stage patients, allows for proactive intervention and better patient outcomes, especially in high-risk populations (e.g., those over 65 with diabetes or CKD). It can also help overcome social determinants of health barriers by enabling testing in various care settings.

The Vivio System is designed for ease of use with an application accessible on mobile tablets and effortless Bluetooth connectivity for its ECG component. It provides clinical documentation logic to support accurate heart failure diagnosis and compliant clinical documentation, suggesting potential for integration with existing electronic health record (EHR) systems to streamline workflows and documentation.

Products by Ventric Health

1 product in the directory

Vivio® LVEDP System
Ventric Health
Cardiology AI
Vivio® is the first and only medical device to enable non-invasive diagnosis of heart failure within clinical or home health care environments, leveraging advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP).

Reviews & Opinions

No web reviews on file yet for Ventric Health. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Ventric Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ventric Health →

View all on YouTube

Press & Coverage

Ventric Health / PR Newswire
Ventric Health's Vivio System Demonstrates High Scalability and Operational Feasibility for Population-Level Heart Failure Screening in New Peer-Reviewed Study
A new multicenter study published in Physiological Measurement highlights the Vivio System's effectiveness in population-level heart failure screening, showing high diagnostic success and substantial disease detection in at-risk individuals. The study demonstrates the system's ability to integrate into scalable care models and identify asymptomatic Stage B patients.
2026-06
PR Newswire
Ventric Health Launches Redesigned Website to Advance Earlier Heart Failure Detection
Ventric Health has launched a redesigned website to better highlight clinical evidence and streamline access to its Vivio System for outpatient heart failure diagnosis. The updated site emphasizes the stakes of late diagnosis and the Vivio System's role in earlier detection.
2026-05
Medical Product Outsourcing
Study Demonstrates High Accuracy of Ventric Health's Heart Failure Detection Tool
A new study published in the Journal of the American Heart Association indicates that Ventric Health's Vivio System is the first technology to accurately and non-invasively measure left ventricular end-diastolic pressure (LVEDP), a key indicator of heart failure. The FDA-approved system showed high sensitivity and specificity in detecting heart failure in a five-minute primary care office test.
2026-01
Medical Economics
Ventric Health study shows primary care tool can identify hidden heart failure cases
New findings published in JACC: Advances demonstrate that Ventric Health's Vivio System, combined with a symptom questionnaire, accurately identified previously undiagnosed heart failure patients in primary care settings. The study involved screening over 2,000 high-risk patients and found a significant percentage with elevated LVEDP.
2025-08
Business Wire
New Study Demonstrates Vivio System From Ventric Health Enables Early Detection of Heart Failure and Effective Triage of Symptomatic Patients in Primary Care Setting
Ventric Health announced the publication of a study in JACC: Advances, showing its Vivio System, when used with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), accurately identified undiagnosed heart failure patients in primary care. This enables earlier intervention and improved patient management.
2025-08
DAIC
Ventric Health Begins Study on Effectiveness of Non-Invasive Vivio System
Ventric Health has initiated a new study to compare its non-invasive Vivio System with the invasive CardioMEMS implant for monitoring heart failure status. The study aims to evaluate how non-invasive LVEDP measurements compare to invasive pulmonary artery pressure measurements.
2025-10
Medical Economics
Ventric Health's noninvasive test shows promise for earlier detection of heart failure
Outcomes from an FDA validation study of Ventric Health's Vivio System, published in the Journal of the American Heart Association, demonstrate its ability to accurately detect heart failure by noninvasively measuring LVEDP. The system achieved 80% sensitivity and 83% specificity in detecting heart failure.
2025-12
Medical Product Outsourcing
Ventric Health Nabs FDA Clearance for Vivio
Ventric Health announced that its Vivio System received FDA 510(k) clearance to aid in the diagnosis of heart failure. This non-invasive device uses advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP) in clinical and home healthcare environments.
2023-10

Frequently Asked Questions

Ventric Health is a medical technology company primarily focused on the earlier detection of heart failure. Their core product, the Vivio System, non-invasively measures Left Ventricular End-Diastolic Pressure (LVEDP), which is a definitive indicator of heart failure, aiming to identify the condition before symptoms significantly worsen.
The Vivio System is the first and only FDA-cleared medical device that non-invasively measures LVEDP, the hallmark of heart failure, in a quick, five-minute test. It utilizes a modified blood pressure cuff, a Bluetooth-enabled ECG, and advanced algorithms to provide real-time results, offering a non-invasive alternative to traditional, often invasive, diagnostic methods like cardiac catheterization.
Yes, the Vivio System is designed for use in both primary care offices and home health care environments. Its portability and ease of use allow clinicians to perform the five-minute test in various settings, expanding access to early heart failure diagnosis and helping overcome barriers to care for at-risk populations.
Ventric Health's Vivio System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance enables clinicians to non-invasively diagnose heart failure within both clinical and home health care settings, ensuring the device meets established regulatory standards for safety and effectiveness.
While specific details on comprehensive support programs are not explicitly outlined, Ventric Health's mission to enable widespread adoption implies a commitment to supporting clinicians. They provide resources including clinical studies and white papers, and aim to ensure their solutions are aligned with real-world care pathways for successful integration and optimal use.
Ventric Health actively seeks to foster partnerships with healthcare providers, academic institutions, and industry leaders to drive innovation and improve patient outcomes. They collaborate with value-based care organizations and payers to expand their heart failure management model and make advanced, non-invasive testing more accessible.
Founded in 2014, Ventric Health has secured significant funding, including $13.1 million, demonstrating investor confidence. Their Vivio System is already in use across the country, with nearly 30,000 tests performed, indicating growing market adoption and a stable operational presence.

Investors

Who's funded Ventric Health.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.